Universidade Norte do Paraná   Report issue

Academic/Hospital Phase 3
Founded: Londrina Brazil (1972)

Organization Overview

First Clinical Trial
2018
NCT03378596
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Juliano Casonatto | Universidade Norte do Paraná

Active Ingredients

Drugs in Phase 3 Trials (1)

caffeine (1 trial)

Drugs in Other Trials (4)

arginine (1 trial)

citrulline (1 trial)

collagen (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cellulitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5